CRISPR genome editing is revolutionizing medicine. Rapid market growth, fueled by startups and new therapies, brings ethical ...

Discover how genetic mutations, like BRCA1 and BRCA2, impact cancer risk and personalized treatment strategies.

The grant, funded by the National Institutes of Health through its Somatic Cell Genome Editing Program (SCGE), will support research to further advance prime editing, a new and more versatile form of ...

Corteva has vast internal expertise. But it doesn’t have a monopoly on good ideas, says the head of its new Corteva Catalyst ...

CRISPRkit aims to make "gene editing accessible for everyone, everywhere." Aimed at K-12 students and people of any age ...

Genome editing with CRISPR and other tools is an exciting new technology with myriad applications from human health ...

A $14M grant will fund research on gene-editing therapies for rare metabolic diseases at the Perelman School of Medicine at the University of Pennsylvania (Penn) and Children's Hospital of ...

Yanan Zhu, an analyst from Wells Fargo, has initiated a new Buy rating on Intellia Therapeutics (NTLA). Yanan Zhu has given his Buy rating due ...

Scientists at St. Jude Children's Research Hospital have revealed how Fanzor2's divergence from bacterial ancestors may make ...

Prof Marc Zimmer from Connecticut College details the rapid advances in AI and genetic engineering and the value for biotech ...

Scientists have revealed how Fanzor2's divergence from bacterial ancestors may make it a useful tool for future genomic engineering endeavors.